Differences in Toxicity and Outcomes in Clinical Trial Participants From Minority Populations,

Increasing the percentage of Black men in clinical trials will improve the understanding of the biologic drivers of racial disparities in prostate cancer., Increasing the percentage of Black men in clinical trials will improve the understanding of the biologic drivers of racial disparities in prostate cancer., Read More

Scroll to Top